| The incidence of narcolepsy in Europe: before, during, and after the influenza A (H1N1) pdm09 pandemic and vaccination campaigns L Wijnans, C Lecomte, C de Vries, D Weibel, C Sammon, A Hviid, ... Vaccine 31 (8), 1246-1254, 2013 | 299 | 2013 |
| Fish oil and mental health: the role of n-3 long-chain polyunsaturated fatty acids in cognitive development and neurological disorders A Assisi, R Banzi, C Buonocore, F Capasso, V Di Muzio, F Michelacci, ... International clinical psychopharmacology 21 (6), 319-336, 2006 | 152 | 2006 |
| Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data M DeSilva, FM Munoz, M Mcmillan, AT Kawai, H Marshall, KK Macartney, ... Vaccine 34 (49), 6015, 2016 | 145 | 2016 |
| Vasculitis as an adverse event following immunization–systematic literature review C Bonetto, F Trotta, P Felicetti, GS Alarcón, C Santuccio, NS Bachtiar, ... Vaccine 34 (51), 6641-6651, 2016 | 120 | 2016 |
| Synthesis and Pharmacological Evaluation of Potent and Highly Selective D3 Receptor Ligands: Inhibition of Cocaine-Seeking Behavior and the Role of Dopamine D3/D … G Campiani, S Butini, F Trotta, C Fattorusso, B Catalanotti, F Aiello, ... Journal of medicinal chemistry 46 (18), 3822-3839, 2003 | 115 | 2003 |
| Discovery of a New Class of Potential Multifunctional Atypical Antipsychotic Agents Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors … S Butini, S Gemma, G Campiani, S Franceschini, F Trotta, M Borriello, ... Journal of medicinal chemistry 52 (1), 151-169, 2009 | 102 | 2009 |
| Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: when differences have an impact on clinical practice F Trotta, HGM Leufkens, JHM Schellens, R Laing, G Tafuri Journal of Clinical Oncology 29 (16), 2266-2272, 2011 | 87 | 2011 |
| Stopping a trial early in oncology: for patients or for industry? F Trotta, G Apolone, S Garattini, G Tafuri Annals of Oncology 19 (7), 1347-1353, 2008 | 68 | 2008 |
| Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination F Galeotti, M Massari, R D’Alessandro, E Beghi, A Chio, G Logroscino, ... European journal of epidemiology 28, 433-444, 2013 | 64 | 2013 |
| Henoch-Schönlein purpura and drug and vaccine use in childhood: a case-control study L Da Dalt, C Zerbinati, MS Strafella, S Renna, L Riceputi, P Di Pietro, ... Italian journal of pediatrics 42, 1-5, 2016 | 59 | 2016 |
| Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort study F Trotta, R Da Cas, SS Alegiani, M Gramegna, M Venegoni, C Zocchetti, ... Bmj 348, 2014 | 59 | 2014 |
| Off-label use of medicines in children: can available evidence avoid useless paediatric trials? The case of proton pump inhibitors for the treatment of gastroesophageal reflux … G Tafuri, F Trotta, HGM Leufkens, N Martini, L Sagliocca, G Traversa European journal of clinical pharmacology 65, 209-216, 2009 | 59 | 2009 |
| Kounis Syndrome: An analysis of spontaneous reports from international pharmacovigilance database F Renda, G Landoni, F Trotta, D Piras, G Finco, P Felicetti, G Pimpinella, ... International journal of cardiology 203, 217-220, 2016 | 55 | 2016 |
| Spontaneous reports of vasculitis as an adverse event following immunization: a descriptive analysis across three international databases P Felicetti, F Trotta, C Bonetto, C Santuccio, YB Pernus, D Burgner, ... Vaccine 34 (51), 6634-6640, 2016 | 51 | 2016 |
| Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors for Developing Effective Antipsychotics: Synthesis, Biological Characterization, and … M Brindisi, S Butini, S Franceschini, S Brogi, F Trotta, S Ros, A Cagnotto, ... Journal of medicinal chemistry 57 (22), 9578-9597, 2014 | 51 | 2014 |
| How do the EMA and FDA decide which anticancer drugs make it to the market? A comparative qualitative study on decision makers’ views G Tafuri, P Stolk, F Trotta, M Putzeist, HG Leufkens, RO Laing, ... Annals of oncology 25 (1), 265-269, 2014 | 50 | 2014 |
| Feasibility and challenges of independent research on drugs: the Italian medicines agency (AIFA) experience S Bonini, M del Zompo, L Francavilla, E Garaci, S Garattini, A Liberati, ... European Journal of Clinical Investigation 40 (1), 69-86, 2009 | 49 | 2009 |
| Drug use and upper gastrointestinal complications in children: a case–control study M Bianciotto, E Chiappini, I Raffaldi, C Gabiano, PA Tovo, S Sollai, ... Archives of disease in childhood 98 (3), 218-221, 2013 | 47 | 2013 |
| Novel atypical antipsychotic agents: rational design, an efficient palladium-catalyzed route, and pharmacological studies G Campiani, S Butini, C Fattorusso, F Trotta, S Gemma, B Catalanotti, ... Journal of medicinal chemistry 48 (6), 1705-1708, 2005 | 46 | 2005 |
| Determinants of price negotiations for new drugs. The experience of the Italian Medicines Agency F Villa, M Tutone, G Altamura, S Antignani, A Cangini, I Fortino, ... Health policy 123 (6), 595-600, 2019 | 45 | 2019 |
